Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 Anti-Sense And Anti-Gene 1.4.3 Short Inhibitory Sequences 1.4.4 Gene Transfer Therapy 1.4.5 Nucleoside Analogs 1.4.6 Ribozymes 1.4.7 Aptamers 1.5 Market by Application 1.5.1 Global Nucleic Acid-based Therapeutics Market Share by Application (2014-2025) 1.5.2 Monogenetic Disorders 1.5.3 Multi-Genetic Disorders 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Nucleic Acid-based Therapeutics Market Size 2.2 Nucleic Acid-based Therapeutics Growth Trends by Regions 2.2.1 Nucleic Acid-based Therapeutics Market Size by Regions (2014-2025) 2.2.2 Nucleic Acid-based Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Nucleic Acid-based Therapeutics Market Size by Manufacturers 3.1.1 Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Nucleic Acid-based Therapeutics Key Players Head office and Area Served 3.3 Key Players Nucleic Acid-based Therapeutics Product/Solution/Service 3.4 Date of Enter into Nucleic Acid-based Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) 4.2 Global Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Nucleic Acid-based Therapeutics Market Size (2014-2019) 5.2 Nucleic Acid-based Therapeutics Key Players in United States 5.3 United States Nucleic Acid-based Therapeutics Market Size by Type 5.4 United States Nucleic Acid-based Therapeutics Market Size by Application 6 Europe 6.1 Europe Nucleic Acid-based Therapeutics Market Size (2014-2019) 6.2 Nucleic Acid-based Therapeutics Key Players in Europe 6.3 Europe Nucleic Acid-based Therapeutics Market Size by Type 6.4 Europe Nucleic Acid-based Therapeutics Market Size by Application 7 China 7.1 China Nucleic Acid-based Therapeutics Market Size (2014-2019) 7.2 Nucleic Acid-based Therapeutics Key Players in China 7.3 China Nucleic Acid-based Therapeutics Market Size by Type 7.4 China Nucleic Acid-based Therapeutics Market Size by Application 8 Japan 8.1 Japan Nucleic Acid-based Therapeutics Market Size (2014-2019) 8.2 Nucleic Acid-based Therapeutics Key Players in Japan 8.3 Japan Nucleic Acid-based Therapeutics Market Size by Type 8.4 Japan Nucleic Acid-based Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Nucleic Acid-based Therapeutics Market Size (2014-2019) 9.2 Nucleic Acid-based Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type 9.4 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application 10 India 10.1 India Nucleic Acid-based Therapeutics Market Size (2014-2019) 10.2 Nucleic Acid-based Therapeutics Key Players in India 10.3 India Nucleic Acid-based Therapeutics Market Size by Type 10.4 India Nucleic Acid-based Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Nucleic Acid-based Therapeutics Market Size (2014-2019) 11.2 Nucleic Acid-based Therapeutics Key Players in Central & South America 11.3 Central & South America Nucleic Acid-based Therapeutics Market Size by Type 11.4 Central & South America Nucleic Acid-based Therapeutics Market Size by Application 12 International Players Profiles 12.1 Wave Life Sciences 12.1.1 Wave Life Sciences Company Details 12.1.2 Company Description and Business Overview 12.1.3 Nucleic Acid-based Therapeutics Introduction 12.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.1.5 Wave Life Sciences Recent Development 12.2 Imugene 12.2.1 Imugene Company Details 12.2.2 Company Description and Business Overview 12.2.3 Nucleic Acid-based Therapeutics Introduction 12.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.2.5 Imugene Recent Development 12.3 Caperna 12.3.1 Caperna Company Details 12.3.2 Company Description and Business Overview 12.3.3 Nucleic Acid-based Therapeutics Introduction 12.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.3.5 Caperna Recent Development 12.4 Phylogica 12.4.1 Phylogica Company Details 12.4.2 Company Description and Business Overview 12.4.3 Nucleic Acid-based Therapeutics Introduction 12.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.4.5 Phylogica Recent Development 12.5 Protagonist Therapeutics 12.5.1 Protagonist Therapeutics Company Details 12.5.2 Company Description and Business Overview 12.5.3 Nucleic Acid-based Therapeutics Introduction 12.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.5.5 Protagonist Therapeutics Recent Development 12.6 Benitec Biopharma 12.6.1 Benitec Biopharma Company Details 12.6.2 Company Description and Business Overview 12.6.3 Nucleic Acid-based Therapeutics Introduction 12.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.6.5 Benitec Biopharma Recent Development 12.7 EGEN 12.7.1 EGEN Company Details 12.7.2 Company Description and Business Overview 12.7.3 Nucleic Acid-based Therapeutics Introduction 12.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.7.5 EGEN Recent Development 12.8 BioMedica 12.8.1 BioMedica Company Details 12.8.2 Company Description and Business Overview 12.8.3 Nucleic Acid-based Therapeutics Introduction 12.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.8.5 BioMedica Recent Development 12.9 Transgene 12.9.1 Transgene Company Details 12.9.2 Company Description and Business Overview 12.9.3 Nucleic Acid-based Therapeutics Introduction 12.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.9.5 Transgene Recent Development 12.10 Copernicus Therapeutics 12.10.1 Copernicus Therapeutics Company Details 12.10.2 Company Description and Business Overview 12.10.3 Nucleic Acid-based Therapeutics Introduction 12.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) 12.10.5 Copernicus Therapeutics Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Nucleic Acid-based Therapeutics Key Market Segments Table Key Players Nucleic Acid-based Therapeutics Covered Table Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type 2014-2025 Figure Anti-Sense And Anti-Gene Figures Table Key Players of Anti-Sense And Anti-Gene Figure Short Inhibitory Sequences Figures Table Key Players of Short Inhibitory Sequences Figure Gene Transfer Therapy Figures Table Key Players of Gene Transfer Therapy Figure Nucleoside Analogs Figures Table Key Players of Nucleoside Analogs Figure Ribozymes Figures Table Key Players of Ribozymes Figure Aptamers Figures Table Key Players of Aptamers Table Global Nucleic Acid-based Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Monogenetic Disorders Case Studies Figure Multi-Genetic Disorders Case Studies Figure Nucleic Acid-based Therapeutics Report Years Considered Table Global Nucleic Acid-based Therapeutics Market Size 2014-2025 (Million US$) Figure Global Nucleic Acid-based Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Nucleic Acid-based Therapeutics Market Share by Regions 2014-2019 Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2014-2019 Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Nucleic Acid-based Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Nucleic Acid-based Therapeutics Market Share by Manufacturers in 2018 Table Global Nucleic Acid-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Nucleic Acid-based Therapeutics Product/Solution/Service Table Date of Enter into Nucleic Acid-based Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Nucleic Acid-based Therapeutics Market Size Share by Type (2014-2019) Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2014-2019) Table Global Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Nucleic Acid-based Therapeutics Market Size Share by Application (2014-2019) Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Nucleic Acid-based Therapeutics Revenue Market Share by Application in 2018 Figure United States Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019) Table United States Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Nucleic Acid-based Therapeutics Market Share by Type (2014-2019) Table United States Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Nucleic Acid-based Therapeutics Market Share by Application (2014-2019) Figure Europe Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019) Table Europe Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Nucleic Acid-based Therapeutics Market Share by Type (2014-2019) Table Europe Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Nucleic Acid-based Therapeutics Market Share by Application (2014-2019) Figure China Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019) Table China Nucleic Acid-based Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Nucleic Acid-based Therapeutics Market Share by Type (2014-2019) Table China Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Nucleic Acid-based Therapeutics Market Share by Application (2014-2019) Figure Japan Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019) Table Japan Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Nucleic Acid-based Therapeutics Market Share by Type (2014-2019) Table Japan Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Nucleic Acid-based Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019) Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Application (2014-2019) Figure India Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019) Table India Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Nucleic Acid-based Therapeutics Market Share by Type (2014-2019) Table India Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Nucleic Acid-based Therapeutics Market Share by Application (2014-2019) Figure Central & South America Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019) Table Central & South America Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Nucleic Acid-based Therapeutics Market Share by Type (2014-2019) Table Central & South America Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Nucleic Acid-based Therapeutics Market Share by Application (2014-2019) Table Wave Life Sciences Company Details Table Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) (Million US$) Figure Wave Life Sciences Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Wave Life Sciences Recent Development Table Imugene Company Details Table Imugene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure Imugene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Imugene Recent Development Table Caperna Company Details Table Caperna Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure Caperna Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Caperna Recent Development Table Phylogica Company Details Table Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure Phylogica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Phylogica Recent Development Table Protagonist Therapeutics Company Details Table Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure Protagonist Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Protagonist Therapeutics Recent Development Table Benitec Biopharma Company Details Table Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure Benitec Biopharma Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Benitec Biopharma Recent Development Table EGEN Company Details Table EGEN Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure EGEN Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table EGEN Recent Development Table BioMedica Company Details Table BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure BioMedica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table BioMedica Recent Development Table Transgene Company Details Table Transgene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure Transgene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Transgene Recent Development Table Copernicus Therapeutics Company Details Table Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$) Figure Copernicus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019) Table Copernicus Therapeutics Recent Development Table Global Nucleic Acid-based Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions (2019-2025) Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions in 2025 Figure United States Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Nucleic Acid-based Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Nucleic Acid-based Therapeutics Market Size by Product (2019-2025) Figure Global Nucleic Acid-based Therapeutics Market Size by Product in 2025 Table Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2025) Figure Global Nucleic Acid-based Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Wave Life Sciences Imugene Caperna Phylogica Protagonist Therapeutics Benitec Biopharma EGEN BioMedica Transgene Copernicus Therapeutics